| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/18/2007 | WO2007006094A1 Wheat pigment |
| 01/18/2007 | WO2007006087A1 Tartaric and ascorbic acid biosynthetic pathways in plants: role of l-idonate dehydrogenase |
| 01/18/2007 | WO2007006079A1 Management of plant pathogens |
| 01/18/2007 | WO2006131953A3 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006124820A3 Materials and methods for regulating blood flow |
| 01/18/2007 | WO2006124784A3 Regulated vectors for selection of cells exhibiting desired phenotypes |
| 01/18/2007 | WO2006123248A3 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 01/18/2007 | WO2006122542A3 Non-viral vector system for transporting nucleic acid into the lungs |
| 01/18/2007 | WO2006116181A3 Regulatory t cell mediator proteins and uses thereof |
| 01/18/2007 | WO2006113526A3 Prevention of chlamydia infection using a protective antibody |
| 01/18/2007 | WO2006113220A3 Transgenic mammals expressing human preproinsulin |
| 01/18/2007 | WO2006110309A3 Transgenic mice expressing a unique b cell population and methods of use |
| 01/18/2007 | WO2006083514A3 Transgenic production of spider silk |
| 01/18/2007 | WO2006079565A3 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 01/18/2007 | WO2006076231A3 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 01/18/2007 | WO2006074166A3 Rnai agents for maintenance of stem cells |
| 01/18/2007 | WO2006065272A3 Methods for altering acetic acid production and enhancing cell death in bacteria |
| 01/18/2007 | WO2006063182A3 Orthopic reconstituted human breast tumor model in mouse |
| 01/18/2007 | WO2006061521A3 Polynucleotide sequences with promoter activity specific of plant roots |
| 01/18/2007 | WO2006061174A3 Rhamnose promoter expression system |
| 01/18/2007 | WO2006060699A3 Methods of increasing seed yield |
| 01/18/2007 | WO2006056464A3 Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4) |
| 01/18/2007 | WO2006056306A3 Hydrogel polymeric conjugates of a prodrug |
| 01/18/2007 | WO2006055851A3 Genetic loci associated with sclerotinia tolerance in soybean |
| 01/18/2007 | WO2006041290A3 Nucleic acids against viruses , in particular hiv |
| 01/18/2007 | WO2006033756A3 Multiple rna polymerase iii promoter expression constructs |
| 01/18/2007 | WO2005117991A3 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 01/18/2007 | WO2005113017A3 Gfap-based gene therapy for treatment of retinal diseases |
| 01/18/2007 | WO2005111058A9 Intracellular delivery of osteoinductive proteins and peptides |
| 01/18/2007 | WO2005098043A3 Ligand-dependent protein splicing |
| 01/18/2007 | WO2005098007A3 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2004087047A3 Mutants of replication competent vaccinia virus |
| 01/18/2007 | WO2004061122A3 Cell proliferation-related polypeptides and uses therefor |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | WO2004042348A3 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |
| 01/18/2007 | US20070016983 Controlling gene expressions in plastids |
| 01/18/2007 | US20070016982 Transgenic plants with increased titerpene saponin levels |
| 01/18/2007 | US20070016981 Plant seed oil of a rapeseed plant having endogenous saturated fatty acids comprising from 22.9% to 26.3% stearate; compositions and methods of use of plant desaturase enzymes, especially Delta -9 desaturases, are provided; use in genetic engineering of plants |
| 01/18/2007 | US20070016980 viral replicase binds to the geminiviral origin of replication to stimulate replication of the targeting vector, whereby homologous recombination between target modifying polynucleotide and the target polynucleotide produces a modified target polynucleotide |
| 01/18/2007 | US20070016979 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/18/2007 | US20070016978 Plants having an enhanced resistance to necrotrophic pathogens and method of making same |
| 01/18/2007 | US20070016977 Gene resistant to aphis gossypii |
| 01/18/2007 | US20070016975 Methods and compositions for reduced putrescine methyl transferase and reduced quinolate phosphoribosyl transferase in plants |
| 01/18/2007 | US20070016974 Nucleic acid molecules and other molecules associated with plants |
| 01/18/2007 | US20070016973 Selective plant growth using D-amino acids |
| 01/18/2007 | US20070016971 Constitutive promoter from the Taro bacilliform virus (TaBV) for expression of foreign or endogenous coding sequences in plants; transcript capable of modulating expression of a target gene; Alomae disease of taro (Colocasia esculenta), badnavirus |
| 01/18/2007 | US20070016968 Treatment of pain through expression of opioid receptors |
| 01/18/2007 | US20070016966 Nonhuman model animal suffering from gillain-barre syndrome and/or fisher syndrome |
| 01/18/2007 | US20070016383 Method for the evolutionary design of biochemical reaction networks |
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015906 Novel essential fungal polynucleotides, polypeptides, and methods of use |
| 01/18/2007 | US20070015725 2-azapurine compounds and their uses |
| 01/18/2007 | US20070015723 Antiviral oligonucleotides having a conserved G4 core sequence |
| 01/18/2007 | US20070015722 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA |
| 01/18/2007 | US20070015721 Hiv-gag codon-optimised dna vaccines |
| 01/18/2007 | US20070015677 hydrolase enzymes comprising amino acid sequence having replacements, deletions or insertion , used in cleaning compounds or detergents having improved wash performance on egg stains |
| 01/18/2007 | US20070015282 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 01/18/2007 | US20070015281 Ready-to-use electroporation cuvette including frozen electrocompetent cells |
| 01/18/2007 | US20070015280 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
| 01/18/2007 | US20070015269 Crystals of DPP-IV |
| 01/18/2007 | US20070015266 Using amylase to hydrolyze starch for use in fermentation of ethanol |
| 01/18/2007 | US20070015265 Derived from Achromobacter xylosoxidans; improved thermostability, storage stability and cost efficiency; industrial scale production of a 2-keto-3-deoxyaldonic acid |
| 01/18/2007 | US20070015261 Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
| 01/18/2007 | US20070015260 Synthesis of synthons for the manufacture of bioactive compounds |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015256 molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; cell comprising the recombinant expression vector |
| 01/18/2007 | US20070015255 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/18/2007 | US20070015253 Heterologous; biologically active protein fused via a proteolytic cleavage site to a latency associated peptide which having a precursor domain of transforming growth factor beta; overcomes the toxic effect of systemic administration of potent biological agents |
| 01/18/2007 | US20070015252 Corynebacterium glutamicum genes encoding regulatory proteins |
| 01/18/2007 | US20070015251 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 01/18/2007 | US20070015249 Chondroitin polymerase and DNA encoding the same |
| 01/18/2007 | US20070015248 Expression vector and use thereof |
| 01/18/2007 | US20070015245 Production of a highly active, soluble form of the cytochrome P450 reductase (CPR A) from Candida tropicalis |
| 01/18/2007 | US20070015244 System for antibody expression and assembly |
| 01/18/2007 | US20070015241 Sulfur atom-free enzyme protein |
| 01/18/2007 | US20070015240 Modified hydrolase comprising ion binding site with enhanced storage stability and improved performance in washing and cleaning; detergents; biodegradation |
| 01/18/2007 | US20070015238 Production of pseudotyped recombinant AAV virions |
| 01/18/2007 | US20070015237 Production of carotenoids in oleaginous yeast and fungi |
| 01/18/2007 | US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015216 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states, comparing |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070015182 Generation of single-strand circular DNA from linear self-annealing segments |
| 01/18/2007 | US20070015177 Nucleic acid extraction method |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015163 Novel full-length cDNA |
| 01/18/2007 | US20070015161 Drug screening for mitotic inhibitor drugs; cancer |
| 01/18/2007 | US20070015160 Method of diagnosing disease relating to endometriosis |
| 01/18/2007 | US20070015159 Methods for detecting aneuploidy using microparticle multiplex detection |
| 01/18/2007 | US20070015142 Detection of HIV-1 by nucleic acid amplification |
| 01/18/2007 | US20070014890 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014817 Methods for detecting virulent Plasmodium, for evaluating Plasmodium virulence, and for screening new drugs employing the 3'UTR of Plasmodium SUB2 and the Plasmodium SUB2 serine protease |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |